China Biotech Services (8037.HK) cooperates with the National Institute for Viral Disease Control and Prevention, China CDC for developing a new generation of Genetically Engineered Recombinant Vaccine

HONG KONG, Oct 5, 2020 – (ACN Newswire) – China Biotech Services (8037.HK) announced that its wholly-owned subsidiary Shenzhen Genius Biotech Services Co., Ltd. (“Shenzhen Genius”) and the National Institute … Read More

China Biotech Services (8037.HK) corporates with the National Institute for Viral Disease Control and Prevention, China CDC for developing a new generation of Genetically Engineered Recombinant Vaccine

HONG KONG, Oct 5, 2020 – (ACN Newswire) – China Biotech Services (8037.HK) announced that its wholly-owned subsidiary Shenzhen Genius Biotech Services Co., Ltd. (“Shenzhen Genius”) and the National Institute … Read More